Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment. Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
The gene expression profiling between Control and Luteolin in 22Rv1 Overall design: Two-condition experiment, Control vs. Luteolin. 22Rv1 cells were treated 25 μM luteolin for 48 hours.
创建时间：
2019-02-21
